No worries. I’ll be sure to send through to various fund managers I know. I’ll also provide them with an update of fair value levels which remains between $0.175 to $0.19.
- Forums
- ASX - By Stock
- EYE
- CMS Proposes Major Increase in Reimbursement for Canaloplasty
CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-438
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
|
|||||
Last
21.0¢ |
Change
-0.010(4.55%) |
Mkt cap ! $48.67M |
Open | High | Low | Value | Volume |
22.5¢ | 22.5¢ | 21.0¢ | $74.08K | 343.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 405339 | 21.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.5¢ | 43631 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 406739 | 0.210 |
5 | 113536 | 0.205 |
14 | 180879 | 0.200 |
1 | 5000 | 0.195 |
1 | 27027 | 0.185 |
Price($) | Vol. | No. |
---|---|---|
0.215 | 47231 | 5 |
0.220 | 1400 | 1 |
0.225 | 50000 | 1 |
0.230 | 50000 | 1 |
0.235 | 122995 | 2 |
Last trade - 15.55pm 13/08/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online